- Home
- GEVO vs HQL Comparison
GEVO vs HQL Comparison
Compare GEVO & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- HQL
- Stock Information
- Founded
- GEVO 2005
- HQL 1992
- Country
- GEVO United States
- HQL United States
- Employees
- GEVO N/A
- HQL N/A
- Industry
- GEVO Major Chemicals
- HQL Investment Managers
- Sector
- GEVO Industrials
- HQL Finance
- Exchange
- GEVO Nasdaq
- HQL Nasdaq
- Market Cap
- GEVO 330.4M
- HQL 364.0M
- IPO Year
- GEVO 2011
- HQL N/A
- Fundamental
- Price
- GEVO $1.19
- HQL $13.00
- Analyst Decision
- GEVO Buy
- HQL
- Analyst Count
- GEVO 2
- HQL 0
- Target Price
- GEVO $8.63
- HQL N/A
- AVG Volume (30 Days)
- GEVO 3.9M
- HQL 120.9K
- Earning Date
- GEVO 05-01-2025
- HQL 01-01-0001
- Dividend Yield
- GEVO N/A
- HQL 11.56%
- EPS Growth
- GEVO N/A
- HQL N/A
- EPS
- GEVO N/A
- HQL 0.79
- Revenue
- GEVO $15,589,000.00
- HQL N/A
- Revenue This Year
- GEVO N/A
- HQL N/A
- Revenue Next Year
- GEVO $917.63
- HQL N/A
- P/E Ratio
- GEVO N/A
- HQL $17.08
- Revenue Growth
- GEVO 16.59
- HQL N/A
- 52 Week Low
- GEVO $0.48
- HQL $11.34
- 52 Week High
- GEVO $3.39
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- GEVO 29.47
- HQL 36.99
- Support Level
- GEVO $1.17
- HQL $12.69
- Resistance Level
- GEVO $1.28
- HQL $13.31
- Average True Range (ATR)
- GEVO 0.12
- HQL 0.24
- MACD
- GEVO -0.01
- HQL -0.05
- Stochastic Oscillator
- GEVO 10.00
- HQL 25.40
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.